Immunomodulatory effects in a phase II study of lenalidomide combined with cetuximab in refractory KRAS-mutant metastatic colorectal cancer patients (Q28534976)
Jump to navigation
Jump to search
scientific article (publication date: 2013)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunomodulatory effects in a phase II study of lenalidomide combined with cetuximab in refractory KRAS-mutant metastatic colorectal cancer patients |
scientific article (publication date: 2013) |
Statements
Immunomodulatory effects in a phase II study of lenalidomide combined with cetuximab in refractory KRAS-mutant metastatic colorectal cancer patients (English)
0 references
2013
0 references
8
0 references
11
0 references
e80437
0 references
11 November 2013
1 reference
LIMMA
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference